• 한국산학기술학회논문지
• /
• 제13권3호
• /
• pp.1042-1053
• /
• 2012

본 연구의 목적은 중년여성이 뉴로피드백(NF) 또는 두개천골요법(CST) 및 병용요법(CT:NF+CST)을 받고난 후 경험한 효과를 확인하고자 하는 것이다. 연구참여자는 S시 M동에 거주하는 중년여성으로서 NF군 17명, CST군 17명, CT군 19명, 총 53명이었다. 2007년 10월 8일부터 12월 14일까지 10주 동안 NF 30회, CST 10회, CT는 NF 30회의 훈련과 CST 10회가 시술되었고, 자료는 각각의 요법을 시술받는 동안 경험한 반응을 매일 일지에 자필로 작성하도록 하여 수집되었다. 자료분석은 연구참여자들이 기술한 자료를 토대로 의미 있는 내용을 찾아내어 내용분석 자료를 표출한 후, 각각의 자료를 속성의 유사점과 차이점을 확인하여 분류되었고, 분류된 속성들은 유사한 의미를 갖는 속성끼리 묶어 상위속성으로 범주화하여 명명하였다. 원 자료에서 효과를 진술한 내용 중 의미 있는 것을 뽑은 결과 NF 37개, CST 91개, CT 110개의 내용분석 자료가 표출되었고, 각각의 내용분석 자료를 유사한 것끼리 묶은 결과 NF 22개, CST 63개, CT 68개의 속성으로 분류되었다. 이 속성들은 9개의 상위속성 즉 불편감, 이완감, 신체증상 완화, 정신기능 향상, 신체적 이완, 심리적 이완, 시술자와의 교감, 카타르시스, 기(氣) 경험으로 범주화되었다. 요법 시 가장 많이 나타난 속성을 보면 NF 시에는 훈련 중 졸림, 마음이 편안해 짐, 몸이 가벼워짐, 마음이 가벼워짐 등 이었고, CST 시에는 마음이 편안해짐, 수면 향상, 건강해 짐, 울음, 몸이 편안해짐 등 이었으며, CT 시에는 마음이 편안해짐, 몸이 가벼워짐, 몸이 편안해짐, 수면 향상, 눈물 등 이었다. 결론적으로 NF 또는 CST 및 CT는 중년여성에게 신체적, 심리적 이완효과가 있으므로 중년여성의 심신이완을 위한 보완대체요법으로 활용할 수 있다.

• 대한한방부인과학회지
• /
• 제19권1호
• /
• pp.219-235
• /
• 2006

Purpose : To investigate the medical information related to HRT online and the medical treatment of perimenopausal and postmenopausal women in the Dept. of Ob&Gy Korean Medicine Hospital, after the discontinuance of the WHI trial in U.S, July 2002. Methods : With the key-words "HRT", "Hormone Replacement therapy", "호르몬 대체요법(HRT)", 갱년기 증후군(perimenopausal syndrome)", “폐경기후증후군(postmenopausal syndrome)", I searched for the information from July 2002 to 2005 on DAUM, the representative portal site in Korea, and I've got a grasp of the tendency of the informational propagation on HRT. Moreover, I investigated chief complaints and tendency of give up HRT of the perimenopausal and postmenopausal women(aged between 47 and 60) who visited Dept. of Ob&Gy Korean Medicine Hospital for 2 years and 6 months since July 2002. Results : 1) Searching for the news on DAUM, I found; 2 articles on the methods of HRT: 4 on the positive effects of HRT: 4 on the general items including the positive effects of HRT: 19 on the side effects of HRT: 1 on the insignificant effect of HRT :4 on the apprehensions about HRT: 3 on the strengthening of the criteria on medical fees review: 3 on the discontinuance of HRT: 8 on the alternative materials and medicines to HRT: 4 on the guidance for the phyto-estrogen. 2) I analyzed chief complaints of 120 women. The majority of chief complaints were vasomotor symptoms like hot flush and sweating. There were only 4 patients who wanted to give up HRT. Conclusion : The side effects of HRT were objectively dealt with online but there was not enough effective and continuous guidance. In the case that a woman not on HRT wishes to overcome perimenopausal period through KM therapy, this information may have affected her decision. However, not many women who were already on HRT terminated the therapy for fear of side effects and switched to KM therapy. Promotion of KM therapy in improving health during perimenopausal and postmenopausal period is desperately needed.

• 대한한방부인과학회지
• /
• 제21권4호
• /
• pp.228-236
• /
• 2008

Purpose: The purposes of this study is to provide basic informations on oriental medical research and treatment through analysis of breast cancer patients, who visited M $\mu$ integrative cancer center, O O university East-West neo medical center. Methods: Electronic medical records of 106 breast cancer patients who visited oriental medical center from June 2, 2006 to February 28, 2008 were selected to collect clinical data of those patients. Clinical data were analyzed for types of clinical characteristics, and received therapies. For analysis of survival and recurrence, Kaplan-Meier method was used. All the data were processed and analyzed using SPSS version 13.0. Results: Average age of breast cancer patients, who visited oriental medical center was 48.72 ($\pm$10.13). The stage distribution record indicated stage I (5.8%), stage II (7.0%), stage III (5.8%), and stage IV (81.4%). Original purposes of patients were analyzed to be supplementary treatment for western therapy (68.9%), treatment for recurrence prevention (18.9%), and oriental medical treatment (12.2%) in order. While receiving oriental medical treatment, 60.4% of patients received conventional medical treatment simultaneously. Conclusion: Majority of patients who visited oriental medical hospital were stage IV at terminal stage and mainly visited for the purpose of supportive care. Further clinical study of breast cancer patients is needed to validate the effectiveness of oriental medical treatment based on this study.

• International Journal of Industrial Entomology and Biomaterials
• /
• 제27권2호
• /
• pp.277-281
• /
• 2013

Silkworm powder, which contains 1-deoxynojirimycin (DNJ), is a promising complementary and alternative medicine (CAM) in Korea. Silkworm powder was produced from Yeonnokjam pupae at d 3 of the 5th instar at the National Academy of Agricultural Science. The powder was derivatized with 9-fluorenylmethyl chloroformate (FMOC-Cl), and the DNJ-FMOC content was measured by HPLC. We investigated the content of 1-DNJ in the silkworm powder and its glucose-lowering effect when it was treated at different temperatures. The content of 1-DNJ was the lowest at $150^{\circ}C$, while it was constant at other temperatures. The silkworm extract powder was orally administered to diabetic mice (20 mg/kg/d) for 4 wk. Water intake did not significantly change when compared with the control group (T0). The blood glucose levels significantly decreased when mice where administered silkworm powder treated at $60^{\circ}C$ (T60) compared to the control group, but no difference was observed between the groups T100 and T150. Moreover, the blood levels of TG significantly decreased compared with the control group. Based on these results, we surmise that the properties of the silkworm extract powder were stable upon heating at $100^{\circ}C$ but not at $150^{\circ}C$.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권3호
• /
• pp.1295-1301
• /
• 2015

Background: Cancer imposes a significant economic burden on individuals, families and society. The purpose of this study was to estimate the economic burden of cancer using the healthcare claims and cancer registry data in Korea in 2009. Materials and Methods: The economic burden of cancer was estimated using the prevalence data where patients were identified in the Korean Central Cancer Registry. We estimated the medical, non-medical, morbidity and mortality cost due to lost productivity. Medical costs were calculated using the healthcare claims data obtained from the Korean National Health Insurance (KNHI) Corporation. Non-medical costs included the cost of transportation to visit health providers, costs associated with caregiving for cancer patients, and costs for complementary and alternative medicine (CAM). Data acquired from the Korean National Statistics Office and Ministry of Labor were used to calculate the life expectancy at the time of death, age- and gender-specific wages on average, adjusted for unemployment and labor force participation rate. Sensitivity analysis was performed to derive the current value of foregone future earnings due to premature death, discounted at 3% and 5%. Results: In 2009, estimated total economic cost of cancer amounted to $17.3 billion at a 3% discount rate. Medical care accounted for 28.3% of total costs, followed by non-medical (17.2%), morbidity (24.2%) and mortality (30.3%) costs. Conclusions: Given that the direct medical cost sharply increased over the last decade, we must strive to construct a sustainable health care system that provides better care while lowering the cost. In addition, a comprehensive cancer survivorship policy aimed at lower caregiving cost and higher rate of return to work has become more important than previously considered.